Travere Therapeutics, Inc. (TVTX)
40.96
-1.17
(-2.78%)
USD |
NASDAQ |
Apr 15, 16:00
41.06
+0.10
(+0.24%)
Pre-Market: 08:01
Travere Therapeutics Research and Development Expense (Annual) : 206.01M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Revolution Medicines, Inc. | 978.68M |
| ICU Medical, Inc. | 87.50M |
| Tandem Diabetes Care, Inc. | 174.84M |
| iRhythm Holdings, Inc. | 84.61M |
| Eli Lilly & Co. | 13.34B |